MORNING NEWS

Market strategy by Swissquote Analysts

Sika Hikes Dividend Despite Drop in Profits

By Ludovica SCOTTO DI PERTA
2/19/2026
Construction chemicals and adhesives manufacturer Sika suffered a decline in profits in the 2025 financial year. Negative currency effects, the weak Chinese construction market, and the US government shutdown at the end of the year all contributed to slower growth. As already announced on a provisional basis in January, sales in local currencies shrank by 4.8 percent to CHF 11.20 billion, the company confirmed on Friday.

Zurich: On Track to Meet or Exceed 2027 Targets

By Nadine PEREIRA
2/18/2026
The Zurich Group once again increased its earnings in the 2025 financial year. In view of the positive profit development, the insurer's shareholders are set to benefit from a higher dividend payout. Zurich's operating profit jumped 14 percent to $8.86 billion last year, and net profit climbed 17 percent to $6.80 billion, the company revealed on Thursday. Both figures are record highs.

Amrize Delivers Strong Free Cash Flow in 2025

By Nadine PEREIRA
2/17/2026
Amrize, an American company specializing in building materials, aims to increase both its revenue and operating profit in the current fiscal year. When presenting its figures for 2025, the company issued a forecast for 2026. Sales are expected to rise by 4 to 6 percent to between US$12.29 billion and US$12.52 billion, as announced on Tuesday evening by the company, which was spun off from Holcim last summer. Operating profit (EBITDA), adjusted for special costs, is expected to increase by 8 to 11 percent to between $3.25 billion and $3.34 billion. In 2025, Amrize boosted sales of building materials by 2.2 percent to $8.51 billion, while sales of building envelopes decreased by 2.2 percent to $3.30 billion.

Activist Elliott Builds Big Stake in Norwegian Cruise Line

By Nadine PEREIRA
2/16/2026
Activist Elliott Investment Management has built a more than 10% stake in Norwegian Cruise Line and plans to push for changes to turn the struggling cruise-ship operator around, according to people familiar with the matter. Elliott, now one of Norwegian’s top investors, is planning to engage with the company to try to help fix its underperformance, the people said. Norwegian is the fourth-largest cruise operator in the world by number of passengers, with a market value of roughly $10 billion. Its brands include the more premium Oceania Cruises and the luxury Regent Seven Seas Cruises.

Anthropic Adds New Board Member as It Eyes IPO

By Nadine PEREIRA
2/15/2026
Anthropic’s artificial-intelligence tool Claude was used in the U.S. military’s operation to capture former Venezuelan President Nicolás Maduro, highlighting how AI models are gaining traction in the Pentagon, according to people familiar with the matter. Former Microsoft and General Motors executive Chris Liddell, who helped take the automaker public, has joined Anthropic’s board of directors, the company said. The appointment adds a board member with experience steering a large company through a public listing as Anthropic eyes a potential IPO.

Airbnb Logs Mixed Fourth Quarter Amid Ambitious Investment Plans

By Ludovica SCOTTO DI PERTA
2/12/2026
Airbnb posted higher fourth-quarter revenue but lower profit, as investments in new business drive up expenses. The vacation rental company on Thursday posted a profit of $341 million, or 56 cents a share, in the quarter ended Dec. 31, down from $461 million, or 73 cents a share, a year earlier. Analysts forecast 67 cents a share, according to FactSet. The decline in earnings was due to planned investments in new growth and policy initiatives, as well as a $90 million charge related to non-income tax matters. Total costs and expenses increased 22% from the year before.

McDonald’s Is Beating the Market

By Nadine PEREIRA
2/11/2026
McDonald’s shares stalled in after-hours trading (-0.4%) even though the fast-food chain handily beat expectations for fourth-quarter earnings and revenue. The company reported adjusted earnings of $3.12 a share and revenue of $7.01 billion. Global comparable sales rose 5.7%, and comparable sales in the U.S. rose 6.8%. Wall Street was expecting McDonald’s to show growth as the fast-food chain’s value-led strategies offset the challenge of a tough economy. For the quarter ended in December, analysts polled by FactSet expected McDonald’s to report that net revenue increased by 7% to $6.84 billion. Earnings were expected to come in at $3.04 a share, up from $2.83 a year ago.

Schindler Holding AG Bottom Line Advances In Full Year

By Nadine PEREIRA
2/10/2026
Lift and escalator manufacturer Schindler generated slightly less revenue and orders last year, yet earned significantly more. In the new year, Schindler aims to continue growing moderately and become even more profitable. Overall, revenue fell by 2.6 percent to CHF 10.95 billion, as the Central Swiss group announced on Wednesday. Once again, the strong Swiss franc had a negative impact on the result. Foreign currency effects cost CHF 431 million in sales. In local currencies, sales would have grown by 1.3 percent. Adjusted operating profit (EBIT), on the other hand, increased by 8.2 percent to CHF 1.45 billion. The operating margin improved to 13.3 percent from 12.0 percent in the previous year.

Revenue Growth Accelerates at Gucci Parent Company Kering as Realignment Continues

By Nadine PEREIRA
2/9/2026
Gucci owner Kering has reported accelerated sales growth for the final quarter of 2025. The group is pushing ahead with its restructuring plan to lure customers back into its boutiques. The Paris-based group posted sales of €3.905 billion ($4.65 billion) in the fourth quarter, an important shopping period with Black Friday and Christmas. Although the result represented a 9 percent decline on a year-on-year basis, it was an improvement on the previous quarter. At that time, the company had recorded a 10 percent decline in sales to €3.415 billion.

Roche Sees Efficacy of MS Candidate Fenebrutinib Confirmed

By Nadine PEREIRA
2/8/2026
Roche presented new results from a pivotal study on the experimental drug fenebrutinib at the Actrims conference in California. In patients with primary progressive multiple sclerosis (PPMS), the drug slowed the progression of disability at least as effectively as Ocrevus, the only Roche therapy approved to date.
Follow us

Sponsors
UEFA Europa LeagueGenève ServetteZSC Lions

Be aware of the risk

Trading leveraged products on the Forex platform, such as foreign exchange, spot precious metals and Contracts for Difference (CFDs), involves significant risk of loss due to the leverage and may not be suitable for all investors. Prior to opening an account with Swissquote, consider your level of experience, investment objectives, assets, income and risk appetite. Losses are in theory unlimited and you may be required to make additional payments if your account balance falls below the required margin level and therefore you should not speculate, invest or hedge with capital you cannot afford to lose, that is borrowed or urgently needed or necessary for personal or family subsistence. Over the past 12 months, 73.10% of retail investors have either lost money when trading CFDs, experienced a total loss of their margin at the closing of their position or ended up with a negative balance after closing their position. You should be aware of all the risks associated with foreign exchange trading and seek advice from an independent financial advisor if you have any doubts. For more details, including information on the leverage effect, how margins work, and counterparty and market risks, please refer to our Forex and CFD Risk Disclosure. The content of this website represents advertising material and has not been submitted to nor approved by any supervisory authority.

AI-generated content

Some of the visual content on our website has been generated and/or enhanced using artificial intelligence (AI) applications. However, all content undergoes thorough human review and approval to ensure its accuracy, relevance, and compliance with the needs of our users and clients.